Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2013-06-05

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/03639045.2012.699069PMID 22758209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin E TPGS as a molecular biomaterial for drug delivery.

  2012cited by this paper
• Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells.

  2011cited by this paper
• BSA-FITC-loaded microcapsules for in vivo delivery.

  2009cited by this paper
• Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

  2009cited by this paper
• Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.

  2009cited by this paper
• Formulation and Evaluation of Lidocaine Lipid Nanosystems for Dermal Delivery

  2009cited by this paper
• Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.

  2008cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.

  2007cited by this paper
• Nanoparticles - A Review

  2007cited by this paper
• Preparation and Characterization of Poly-ε-caprolactone Particles for Controlled Insulin Delivery

  2007cited by this paper
• Sustained Release of TGFβ3 from PLGA Microspheres and Its Effect on Early Osteogenic Differentiation of Human Mesenchymal Stem Cells

  2006cited by this paper
• BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems.

  2006cited by this paper
• Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy.

  2006cited by this paper
• Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.

  2006cited by this paper
• Preparation and Characterization of Poly-ε-caprolactone Carrier Particles for Controlled Insulin Delivery

  2006cited by this paper
• Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.

  2006cited by this paper
• Freeze-drying of nanoparticles: formulation, process and storage considerations.

  2006cited by this paper
• Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells.

  2006cited by this paper
• Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

  2005cited by this paper
• Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology

  2005cited by this paper
• Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs

  2005cited by this paper
• Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.

  2004cited by this paper
• Poly-epsilon-caprolactone microspheres and nanospheres: an overview.

  2004cited by this paper
• Poly(ε-caprolactone) and Eudragit® microparticles containing fludrocortisone acetate

  2004cited by this paper
• Poly-ϵ-caprolactone microspheres and nanospheres: an overview

  2004cited by this paper
• Peptide and protein drug delivery to and into tumors: challenges and solutions.

  2003cited by this paper
• Preparation of bupivacaine-loaded poly(epsilon-caprolactone) microspheres by spray drying: drug release studies and biocompatibility.

  2003cited by this paper
• Preparation of bupivacaine-loaded poly(ε-caprolactone) microspheres by spray drying: drug release studies and biocompatibility

  2003cited by this paper
• Clinical translation of angiogenesis inhibitors

  2002cited by this paper
• Somatostatin analogs and radiopeptides in cancer therapy.

  2002cited by this paper
• Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer

  2002cited by this paper
• Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol).

  2002cited by this paper
• Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique.

  2000cited by this paper
• Preparation and characterization of protein-loaded poly(epsilon-caprolactone) microparticles for oral vaccine delivery.

  1999cited by this paper
• Protein-loaded poly(epsilon-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation.

  1999cited by this paper

• Polycaprolactone-based nanocarriers containing 5-fluorouracil as a therapeutic guided drug delivery approach for enhancing anticancer activity.

  2023cites this paper
• Lipid poly (ɛ-caprolactone) hybrid nanoparticles of 5-fluorouracil for sustained release and enhanced anticancer efficacy.

  2021cites this paper
• Rediscovering Tocophersolan: a renaissance for nano-based drug delivery and nanotheranostic applications.

  2020cites this paper
• Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model.

  2019cites this paper
• Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics

  2018cites this paper
• Determination of Formulation Conditions Allowing Double Emulsions Stabilized by PGPR and Sodium Caseinate to Be Used as Capsules.

  2018cites this paper
• Anti prostate cancer using PEGylated bombesin containing, cabazitaxel loading nano-sized drug delivery system

  2016cites this paper
• Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation

  2016cites this paper
• Design and Evaluation of Hydrophobic Ion-Pairing Complexation ofLysozyme with Sodium Dodecyl Sulfate for Improved Encapsulation ofHydrophilic Peptides/Proteins by Lipid-Polymer Hybrid Nanoparticles

  2015cites this paper
• Nanoparticles in the treatment of mental disorders: a new tool in the psychiatric medication.

  2015cites this paper
• Preparation and Characterization of Protein-loaded Lipid-polymer Hybrid Nanoparticles with Polycaprolactone as Polymeric Core Material

  2014cites this paper